R Kariyama Selected Research

arbekacin

4/2001	[Combination therapy against vancomycin-resistant enterococci].
9/2000	Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
1/2000	In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Kariyama Research Topics

Disease

2	Infections 04/2001 - 01/2000
1	Carcinoma (Carcinomatosis) 01/2006
1	Endocarditis 09/2000

Drug/Important Bio-Agent (IBA)

3	arbekacinIBA 04/2001 - 01/2000
2	Ampicillin (Omnipen)FDA LinkGeneric 04/2001 - 09/2000
2	Gentamicins (Gentamicin)FDA LinkGeneric 09/2000 - 01/2000
1	AminoglycosidesIBA 04/2001
1	Vancomycin FDA LinkGeneric 01/2000

Therapy/Procedure

1	Prostatectomy (Retropubic Prostatectomy) 01/2006
1	Therapeutics 04/2001